BerandaNTRA • NASDAQ
add
Natera Inc
$208,04
Setelah Jam Perdagangan Normal:(0,00%)0,00
$208,04
Tutup: 27 Feb, 17.21.11 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$216,10
Rentang hari
$196,22 - $212,99
Rentang tahun
$125,38 - $256,27
Kapitalisasi pasar
28,95Â M USD
Volume Rata-Rata
1,07Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 665,50Â jt | 39,79% |
Biaya operasional | 468,21Â jt | 28,50% |
Penghasilan bersih | 47,26Â jt | 187,89% |
Margin laba bersih | 7,10 | 162,89% |
Penghasilan per saham | 0,36 | 187,80% |
EBITDA | -12,49Â jt | 79,33% |
Tarif pajak efektif | 454,63% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,08Â M | 11,14% |
Total aset | 2,40Â M | 44,41% |
Total liabilitas | 685,93Â jt | 47,41% |
Total ekuitas | 1,71 M | — |
Saham yang beredar | 138,34 jt | — |
Harga terhadap nilai buku | 17,46 | — |
Tingkat pengembalian aset | -2,70% | — |
Tingkat pengembalian modal | -3,39% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 47,26Â jt | 187,89% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Didirikan
1 Jan 2004
Kantor pusat
Situs
Karyawan
4.429